Given their ability to regulate insulin secretion, GLP‐1, and GLP‐1 analogs were first studied as antidiabetic drugs for type II diabetes (Maselli and Camilleri 2021). This evidence concerns the gene GLP1R and type 2 diabetes mellitus.